Introduction Directory UMM :Data Elmu:jurnal:A:Atherosclerosis:Vol152.Issue2.Oct2000:

Atherosclerosis 152 2000 367 – 376 Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population Dolores Corella a , Carmen Sa´iz a , Marisa Guille´n a , Olga Portole´s a , Francisco Mulet a , Jose´ I. Gonza´lez a , Jose´ M. Ordova´s b, a Genetic and Molecular Epidemiology Unit, Public Health Department, School of Medicine, Uni6ersitat de Vale`ncia, Valencia, Spain b JM-USDA Human Nutrition Research Center on Aging at Tufts Uni6ersity, 711 Washington St., Boston, MA 02111 , USA Received 14 June 1999; received in revised form 25 October 1999; accepted 5 November 1999 Abstract Genetic variants at the cholesteryl ester transfer protein CETP locus have been associated with CETP activity and mass, as well as plasma high density lipoprotein cholesterol HDL-C and apolipoprotein A-I levels. We have examined allele frequencies and lipid associations for the common CETP TaqIB polymorphism in a sample of 514 healthy subjects 231 men, mean age 37.4 years, and 283 women, mean age 35.7 years residing in Valencia Spain. The frequency of the less common TaqIB2 allele 0.351; 95 CI: 0.322 – 0.380 was significantly lower than those reported for Northern European populations. Consistent with previous studies, we found a significant association of the TaqIB polymorphism with HDL-C levels. Homozygotes for the B1 allele had lower HDL-C levels than subjects carrying the B2 allele P trend B 0.001 and 0.002, for men and women, respectively. No statistically significant genotype effects were observed for any of the other lipid measures. Multivariate models including TaqIB genotype, body mass index, smoking, alcohol, physical activity, marital status and education were fitted to predict HDL-C levels. The TaqIB polymorphism was consistently an independent predictor of HDL-C levels P B 0.001, and explained 5.8 of its variance. To evaluate gene-environmental interactions, first order interaction terms were tested into the multivariate model. No statistically significant interactions between the TaqIB genotypes and smoking, alcohol, physical activity or education were detected. In conclusion, we observed a significant association of the TaqIB polymorphism with HDL-C levels, which remained consistent across different levels of behavioral factors. Moreover, we found that the TaqIB2 allele frequency was lower in our sample than in other European populations, which could be a contributing factor to the unexpectedly high prevalence of coronary heart disease observed in the region of Valencia. © 2000 Elsevier Science Ireland Ltd. All rights reserved. Keywords : Cholesteryl ester transfer protein; Genetic polymorphisms; High density lipoproteins; Coronary heart disease www.elsevier.comlocateatherosclerosis

1. Introduction

The inverse association between high density lipo- protein – cholesterol HDL-C levels and coronary heart disease CHD risk has been known for over 25 years [1,2]. However, the mechanisms underlying this rela- tionship [3,4] and the factors responsible for the wide distribution of HDL-C concentrations observed in the general population are not yet fully understood. Plasma HDL-C levels are determined by a variety of environmental and genetic factors. Epidemiological studies have demonstrated positive associations be- tween HDL-C concentrations and alcohol consump- tion, estrogens, and exercise, whereas a negative association has been observed with tobacco smoking [5,6]. Our understanding of the genetic factors deter- mining HDL-C levels in the general population is more limited. Preliminary twin and family studies indicated that 40 – 60 of the variation of HDL-C between indi- viduals was determined by genetic factors [7]. CETP is a glycoprotein that plays an important role in the transport of excess cholesterol from peripheral Corresponding author. Tel.: + 1-617-5563102; fax: + 1-617- 5563103. E-mail address : ordovashnrc.tufts.edu J.M. Ordova´s. 0021-915000 - see front matter © 2000 Elsevier Science Ireland Ltd. All rights reserved. PII: S 0 0 2 1 - 9 1 5 0 9 9 0 0 4 7 7 - 3 tissues to the liver. This glycoprotein mediates the transfer of cholesteryl esters from HDL or LDL into triglyceride-rich lipoproteins, and thereby stimulates re- verse cholesterol transport [8]. The CETP mRNA en- codes a polypeptide of Mr53000, which is N-glycosilated at four sites, giving rise to the mature form of CETP of Mr74000 [9]. The CETP gene encom- passes 16 exons and it has been assigned to chromo- some 16 16q21 near the LCAT locus. Sib pair linkage analyses have suggested that variation in HDL-C be- tween individuals was related to the inheritance of alleles at or near the cholesteryl ester transfer protein CETP gene [10]. Several polymorphisms and rare variants have been detected [11,12], and some of these have been shown to have a significant effect on plasma lipid levels [12 – 14]. A common polymorphism detected using TaqI TaqIB has been shown to be a silent base change affecting the 277th nucleotide in the first intron of the CETP gene [15]. The allele carrying the cutting site for the TaqI enzyme is called B1, whereas the one in which the cutting site is missing is known as B2. This polymorphism has been consistently associated with plasma levels of HDL-C, individuals carrying the B2 allele having the highest levels of HDL-C [16 – 18]. However, this association might be population specific [14,19] and highly influenced by environmental factors such as alcohol consumption and tobacco smoking [17,20,21]. Therefore, the aim of this study was to estimate allele frequencies of the TaqIB polymorphism, and to investigate the relationship between this poly- morphism and plasma lipid levels taking into account other biological and environmental factors in a healthy population from Valencia on the Mediterranean coast of Spain. This region presents an unusually high rate of cardiovascular disease that, at the present time, is the highest in the country [22]. The results of this research could contribute to our understanding of the genetic and environmental factors associated with cardiovascu- lar risk.

2. Methods